Mark Purcell
Stock Analyst at Morgan Stanley
(1.73)
# 2,059
Out of 4,413 analysts
5
Total ratings
100%
Success rate
16.94%
Average return
Main Sectors:
Top Industries:
5 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NVS Novartis AG | Initiates: Equal-Weight | $114 | $97.13 | +17.37% | 1 | Jan 23, 2024 | |
| SNY Sanofi | Initiates: Equal-Weight | $55 | $49.23 | +11.72% | 1 | Jan 23, 2024 | |
| GSK GSK | Initiates: Equal-Weight | $44 | $41.44 | +6.18% | 1 | Jan 23, 2024 | |
| AZN AstraZeneca | Initiates: Overweight | $85 | $75.88 | +12.02% | 1 | Jan 23, 2024 | |
| NVO Novo Nordisk | Initiates: Overweight | $120 | $128.31 | -6.48% | 1 | Jan 23, 2024 |
Novartis AG
Jan 23, 2024
Initiates: Equal-Weight
Price Target: $114
Current: $97.13
Upside: +17.37%
Sanofi
Jan 23, 2024
Initiates: Equal-Weight
Price Target: $55
Current: $49.23
Upside: +11.72%
GSK
Jan 23, 2024
Initiates: Equal-Weight
Price Target: $44
Current: $41.44
Upside: +6.18%
AstraZeneca
Jan 23, 2024
Initiates: Overweight
Price Target: $85
Current: $75.88
Upside: +12.02%
Novo Nordisk
Jan 23, 2024
Initiates: Overweight
Price Target: $120
Current: $128.31
Upside: -6.48%